Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

PURPOSE: A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pathan, Ansar A., Minassian, Angela M., Sander, Clare R., Rowland, Rosalind, Porter, David W., Poulton, Ian D., Hill, Adrian V.S., Fletcher, Helen A., McShane, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424417/
https://ncbi.nlm.nih.gov/pubmed/22789508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.06.084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados